Chen, M.-W.;                     Huang, Y.-R.;                     Lo, W.-L.;                     Lee, S.-Y.;                     Lo, S.-N.;                     Wang, S.-M.;                     Chang, K.-W.    
        PSMA-Targeted Radiolabeled Peptide for Imaging and Therapy in Prostate Cancer: Preclinical Evaluation of Biodistribution and Therapeutic Efficacy. Int. J. Mol. Sci. 2025, 26, 7580.
    https://doi.org/10.3390/ijms26157580
    AMA Style
    
                                Chen M-W,                                 Huang Y-R,                                 Lo W-L,                                 Lee S-Y,                                 Lo S-N,                                 Wang S-M,                                 Chang K-W.        
                PSMA-Targeted Radiolabeled Peptide for Imaging and Therapy in Prostate Cancer: Preclinical Evaluation of Biodistribution and Therapeutic Efficacy. International Journal of Molecular Sciences. 2025; 26(15):7580.
        https://doi.org/10.3390/ijms26157580
    
    Chicago/Turabian Style
    
                                Chen, Ming-Wei,                                 Yuan-Ruei Huang,                                 Wei-Lin Lo,                                 Shih-Ying Lee,                                 Sheng-Nan Lo,                                 Shih-Ming Wang,                                 and Kang-Wei Chang.        
                2025. "PSMA-Targeted Radiolabeled Peptide for Imaging and Therapy in Prostate Cancer: Preclinical Evaluation of Biodistribution and Therapeutic Efficacy" International Journal of Molecular Sciences 26, no. 15: 7580.
        https://doi.org/10.3390/ijms26157580
    
    APA Style
    
                                Chen, M.-W.,                                 Huang, Y.-R.,                                 Lo, W.-L.,                                 Lee, S.-Y.,                                 Lo, S.-N.,                                 Wang, S.-M.,                                 & Chang, K.-W.        
        
        (2025). PSMA-Targeted Radiolabeled Peptide for Imaging and Therapy in Prostate Cancer: Preclinical Evaluation of Biodistribution and Therapeutic Efficacy. International Journal of Molecular Sciences, 26(15), 7580.
        https://doi.org/10.3390/ijms26157580